Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
Mei Grace, Ann Colosia, Sorrel Wolowacz, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 742-759
Open Access | Times Cited: 25

Showing 25 citing articles:

Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
Rebecca C. Woodruff, Michael Melgar, Huong Pham, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 602-602
Closed Access | Times Cited: 22
Hospitalizations due to respiratory syncytial virus (RSV) infections in Germany: a nationwide clinical and direct cost data analysis (2010–2019)
Patricia Niekler, David Goettler, Johannes G. Liese, et al.
Infection (2023) Vol. 52, Iss. 5, pp. 1715-1724
Open Access | Times Cited: 21
National trends in prescription drug expenditures and projections for 2024
Eric M. Tichy, James M. Hoffman, Mina Tadrous, et al.
American Journal of Health-System Pharmacy (2024) Vol. 81, Iss. 14, pp. 583-598
Open Access | Times Cited: 11
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States
Seyed M. Moghadas, Affan Shoukat, Carolyn E. Bawden, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 5, pp. 1328-1335
Open Access | Times Cited: 18
Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65
Robert Buynak, Kevin D. Cannon, David DeAtkine, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 8, pp. 1789-1805
Open Access | Times Cited: 5
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Zhanwei Du, Abhishek Pandey, Seyed M. Moghadas, et al.
Nature Medicine (2025)
Open Access
Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
Irene Arduino, Rachele Francese, Andrea Civra, et al.
Antiviral Research (2024) Vol. 226, pp. 105897-105897
Open Access | Times Cited: 4
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review
Carolina Moreno, Ariel Bardach, María Carolina Palermo, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Exploration of health care utilization, social care utilization and costs for individuals discharged from inpatient geriatric care in Sweden - a registry data study
Carl Willers, Rikard Lindqvist, Stefan Fors, et al.
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
“Insights in the RSV L polymerase function and structure”
Brecht Bonneux, Martina Ceconi, Kim Stobbelaar, et al.
Antiviral Research (2025), pp. 106148-106148
Closed Access
Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States
Seyed M. Moghadas, Affan Shoukat, Carolyn E. Bawden, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
Roberto Debbag, Deborah Rudin, Francesca Ceddia, et al.
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review
William P. Hanage, William Schaffner
Infectious Diseases and Therapy (2024)
Open Access | Times Cited: 1
Should We Vaccinate Healthcare Workers Against Respiratory Syncytial Virus?
Klinger Soares Fáico-Filho, Ana Helena Perosa, Nancy Bellei
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 8
Open Access
Recent advances in natural products and derivatives with antiviral activity against respiratory syncytial virus (RSV)
Ameena Tur Rasool, Erguang Li, Ahsan Nazir
Journal of Asian Natural Products Research (2024), pp. 1-24
Closed Access
Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus (RSV) in English primary care: Protocol for the Observational Study of Acute Respiratory Infection (ObservatARI) (Preprint)
Uy Hoang, Utkarsh Agrawal, José M. Ordóñez‐Mena, et al.
JMIR Research Protocols (2024)
Open Access
Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory Infection (Preprint)
Uy Hoang, Utkarsh Agrawal, José M. Ordóñez‐Mena, et al.
(2024)
Closed Access
Performance Assessment of a Multiplex Real-Time PCR Assay for Detection of Viruses Causing Respiratory Tract Infections
Pallavi Upadhyay, Fadhil Surur, Vijay Singh
Diagnostics (2024) Vol. 14, Iss. 21, pp. 2350-2350
Open Access
Clinical evolution and medical resource utilization in adult patients with respiratory syncytial virus infection at a community hospital in Argentina
A Bengolea, Juan Ignacio Ruiz, Celina G. Vega, et al.
(2024)
Open Access
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece
George Gourzoulidis, C. Tzanetakos, Argyro Solakidi, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1232-1232
Open Access
Real‐World Assessment of Economic and Clinical Outcomes in Thai Patients With Respiratory Syncytial Virus Infection Across Age Groups: A Retrospective Cohort Analysis
Win Khaing, Chia Jie Tan, Chanthawat Patikorn, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 11
Open Access
Burden of Respiratory Syncytial Virus Infection in Children and Older Patients Hospitalized with Asthma: A Seven-Year Longitudinal Population-Based Study in Spain
Rosa María Gómez-García, Rodrigo Jiménez‐García, Ana López‐de‐Andrés, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1749-1749
Open Access
An Overview on Disease Burden and Management of Respiratory Syncytial Virus Infections in Older Adults in the Asia‐Pacific Region
Chih‐Cheng Lai, Po‐Ren Hsueh
Reviews in Medical Virology (2024) Vol. 34, Iss. 6
Closed Access

Giovanna Elisa Calabrò, Caterina Rizzo, Alexander Domnich, et al.
PubMed (2024) Vol. 65, Iss. 2 Suppl 1, pp. E1-E159
Closed Access
Hospitalization cost estimates of respiratory syncytial virus and influenza infections in adults in Spain, 2016–2019
Mariana Haeberer, Alejandra López‐Ibáñez de Aldecoa, Suzie Seabroke, et al.
Vaccine (2024) Vol. 46, pp. 126683-126683
Closed Access
Page 1

Scroll to top